AssayIndex
Reports by quarter

Reports submitted in 2025-Q3 · page 7

Kestrel Bioanalytical began contributing; gradient-length normalisation introduced. Median purity for the quarter is 99.03 % area, n=816. Read the 2025-Q3 state-of-the-index report →

816 records21 pagesmedian on this page 99.19 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2025-019687SelankTFCTFC-2504-G2332Medutest2025-Q399.837.6694.8Buyer-sourced1MARGINAL
AX-2025-019567TirzepatideTFCTFC-2507-T1116PeptideMeter2025-Q397.534.1993.4Buyer-sourced0PASS
AX-2025-019251CJC-1295 (no DAC)AMBAMB-2507-S5238Medutest2025-Q399.595.6293.2Buyer-sourced0PASS
AX-2025-018582SemaglutideQYBQYB-2505-U5049Janoshik2025-Q399.574.89107.1Buyer-sourced0PASS
AX-2025-020812TirzepatideCPCCPC-2502-E1731Janoshik2025-Q398.442.55Buyer-sourced2MARGINAL
AX-2025-020531SemaglutideSSASSA-2502-U6907PeptideMeter2025-Q398.025.9189.7Buyer-sourced1MARGINAL
AX-2025-020147MOTS-cERPERP-2508-M9453Nordanalyt2025-Q398.782.14Buyer-sourced0PASS
AX-2025-019731SemaglutideHomopeptideHOMO-2505-V3835Medutest2025-Q398.756.5688.5Buyer-sourced2FAIL
AX-2025-019465BPC-157JEEPJEEP-2504-X7849PeptideMeter2025-Q398.566.77Buyer-sourced0PASS
AX-2025-019312RetatrutideAMBAMB-2502-A6319Janoshik2025-Q397.754.97105.5Buyer-sourced0PASS
AX-2025-019149NAD+GSPGSP-2503-B3620Janoshik2025-Q399.839.9192.2Buyer-sourced0PASS
AX-2025-020973PT-141 (Bremelanotide)WXTWXT-2507-R4042Kestrel2025-Q399.754.62Buyer-sourced0PASS
AX-2025-020663TirzepatideSGNSGN-2506-J8349PeptideMeter2025-Q397.782.57100.7Buyer-sourced0PASS
AX-2025-020414LiraglutideMKMMKM-2508-P4928Janoshik2025-Q397.996.89103.1Buyer-sourced0PASS
AX-2025-019843SemaglutideHomopeptideHOMO-2506-M5731Janoshik2025-Q397.855.54104.3Buyer-sourced1MARGINAL
AX-2025-019637BPC-157TFCTFC-2507-J2316Janoshik2025-Q399.304.4992.1Buyer-sourced2FAIL
AX-2025-019200BPC-157SinoPepSNP-2506-U4547Medutest2025-Q399.305.1692.1Buyer-sourced2FAIL
AX-2025-018498MOTS-cWWBWWB-2505-G2801Medutest2025-Q399.702.69Buyer-sourced0PASS
AX-2025-020710Thymosin α1SGNSGN-2504-P9129Janoshik2025-Q399.485.83100.1Buyer-sourced0PASS
AX-2025-020456TirzepatideKPKP-2504-V5402Kestrel2025-Q398.394.6389.3Buyer-sourced1MARGINAL
AX-2025-020374IpamorelinMKMMKM-2504-N4424Janoshik2025-Q399.125.29107.0Buyer-sourced0PASS
AX-2025-019920IpamorelinHJHJ-2504-X6056Janoshik2025-Q399.526.3788.5Buyer-sourced1MARGINAL
AX-2025-019587TirzepatideTFCTFC-2508-G1453Janoshik2025-Q399.644.09Supplier-supplied0PASS
AX-2025-019558TB-500TFCTFC-2503-L9791Janoshik2025-Q399.235.50Laboratory-retained0PASS
AX-2025-018871BPC-157TFSTFS-{CAT}-8964Medutest2025-Q399.854.75100.4Buyer-sourced0PASS
AX-2025-018865N-Acetyl Semax AmideFGPFGP-2508-R8995Janoshik2025-Q399.179.32103.3Buyer-sourced0PASS
AX-2025-020941SemaglutideWXTWXT-2508-G2836Janoshik2025-Q398.452.8897.3Buyer-sourced0PASS
AX-2025-020801SemaglutideCPCCPC-2504-G1688Nordanalyt2025-Q398.455.08105.7Buyer-sourced0PASS
AX-2025-020137MOTS-cERPERP-2508-M9453Janoshik2025-Q398.881.80Buyer-sourced0PASS
AX-2025-019769RetatrutideHomopeptideHOMO-2508-U3892Kestrel2025-Q399.246.1593.0Buyer-sourced0PASS
AX-2025-019748SelankHomopeptideHOMO-2507-D3703Janoshik2025-Q399.717.63Buyer-sourced0PASS
AX-2025-019582TirzepatideTFCTFC-2508-G1453VendorInvestigate2025-Q399.664.2994.8Buyer-sourced0PASS
AX-2025-019469BPC-157JEEPJEEP-2506-R8215Janoshik2025-Q398.933.43102.5Buyer-sourced0PASS
AX-2025-019392CJC-1295 (no DAC)HYBHYB-2504-N7248Nordanalyt2025-Q399.254.09105.5Buyer-sourced0PASS
AX-2025-019294IpamorelinAMBAMB-2505-J6078Janoshik2025-Q399.934.53100.5Laboratory-retained0PASS
AX-2025-019287CJC-1295 (no DAC)AMBAMB-2508-F5378PeptideMeter2025-Q399.212.97Buyer-sourced0PASS
AX-2025-020880BPC-157WXTWXT-2506-M1881Nordanalyt2025-Q398.943.36Buyer-sourced0PASS
AX-2025-020867IGF-1 LR3WXTWXT-2508-G2536Nordanalyt2025-Q397.054.0387.0Laboratory-retained1MARGINAL
AX-2025-020800SemaglutideCPCCPC-2504-G1688Nordanalyt2025-Q398.665.27106.2Buyer-sourced0PASS
AX-2025-020503CJC-1295 with DACKPKP-2506-L6194Medutest2025-Q399.934.79Buyer-sourced0PASS